Serum KLKB1 as a Potential Prognostic Biomarker for Hepatocellular Carcinoma Based on Data-Independent Acquisition and Parallel Reaction Monitoring.

Yi-Qun Che Yue ZhangHan-Bing LiDi ShenWei Cui

Published in: Journal of hepatocellular carcinoma (2021)

Aberrant expression of KLKB1 was strongly associated with the prognosis of HCC patients. KLKB1 may be used to evaluate the prognosis and guide the treatment for HCC.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
poor prognosis
peritoneal dialysis
prognostic factors
risk assessment
binding protein
deep learning
replacement therapy
combination therapy
long non coding rna
human health
patient reported